Shopping Cart 0
Cart Subtotal
USD 0

Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Active Biotech AB (ACTI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Active Biotech AB (Active Biotech) is a biotechnology company that develops and commercializes pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company's key products in development include Laquinimod (neurodegenerative diseases), Anyara (cancer), Tasquinimod (cancer), Paquinimod (Systemic Sclerosis), and SILC (autoimmune diseases). It has licensing agreements with Teva Pharmaceutical Industries, NeoTX, Ipsen, Teva Neuroscience and MediGene AG. Active Biotech is headquartered in Lund, Sweden.

Active Biotech AB Key Recent Developments

Feb 14,2019 Active Biotech year-end report January-December 2018

Nov 14,2018 Active Biotech-Interim report January-September 2018

Sep 13,2018 TOPC : Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018" [Newswire : Healthcare-GNW RSS]

Sep 07,2018 Teva returns laquinimod global rights to Active Biotech

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Active Biotech AB-Key Facts

Active Biotech AB-Key Employees

Active Biotech AB-Key Employee Biographies

Active Biotech AB-Major Products and Services

Active Biotech AB-History

Active Biotech AB-Company Statement

Active Biotech AB-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Active Biotech AB-Business Description

Active Biotech AB-SWOT Analysis

SWOT Analysis-Overview

Active Biotech AB-Strengths

Active Biotech AB-Weaknesses

Active Biotech AB-Opportunities

Active Biotech AB-Threats

Active Biotech AB-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Active Biotech AB, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 14, 2019: Active Biotech year-end report January-December 2018

Nov 14, 2018: Active Biotech-Interim report January-September 2018

Sep 13, 2018: TOPC : Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018" [Newswire : Healthcare-GNW RSS]

Sep 07, 2018: Teva returns laquinimod global rights to Active Biotech

Aug 09, 2018: Active Biotech-interim report January-June 2018

May 18, 2018: Annual General Meeting of Active Biotech

May 17, 2018: Active Biotech: Interim report January-March 2018

Feb 15, 2018: Active Biotech: Year-end report January-December 2017

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Active Biotech AB, Performance Chart (2014-2018)

Active Biotech AB, Ratio Charts

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Active Biotech AB, Key Facts

Active Biotech AB, Key Employees

Active Biotech AB, Key Employee Biographies

Active Biotech AB, Major Products and Services

Active Biotech AB, History

Active Biotech AB, Subsidiaries

Active Biotech AB, Key Competitors

Active Biotech AB, Ratios based on current share price

Active Biotech AB, Annual Ratios

Active Biotech AB, Annual Ratios (Cont...1)

Active Biotech AB, Interim Ratios

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Active Biotech AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Active Biotech AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Active Biotech AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Company Profile

Company Profile Title

Active Biotech AB (ACTI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Active Biotech AB (Active Biotech) is a biotechnology company that develops and commercializes pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company's key products in development include Laquinimod (neurodegenerative diseases), Anyara (cancer), Tasquinimod (cancer), Paquinimod (Systemic Sclerosis), and SILC (autoimmune diseases). It has licensing agreements with Teva Pharmaceutical Industries, NeoTX, Ipsen, Teva Neuroscience and MediGene AG. Active Biotech is headquartered in Lund, Sweden.

Active Biotech AB Key Recent Developments

Feb 14,2019 Active Biotech year-end report January-December 2018

Nov 14,2018 Active Biotech-Interim report January-September 2018

Sep 13,2018 TOPC : Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018" [Newswire : Healthcare-GNW RSS]

Sep 07,2018 Teva returns laquinimod global rights to Active Biotech

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Active Biotech AB-Key Facts

Active Biotech AB-Key Employees

Active Biotech AB-Key Employee Biographies

Active Biotech AB-Major Products and Services

Active Biotech AB-History

Active Biotech AB-Company Statement

Active Biotech AB-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Active Biotech AB-Business Description

Active Biotech AB-SWOT Analysis

SWOT Analysis-Overview

Active Biotech AB-Strengths

Active Biotech AB-Weaknesses

Active Biotech AB-Opportunities

Active Biotech AB-Threats

Active Biotech AB-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Active Biotech AB, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 14, 2019: Active Biotech year-end report January-December 2018

Nov 14, 2018: Active Biotech-Interim report January-September 2018

Sep 13, 2018: TOPC : Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018" [Newswire : Healthcare-GNW RSS]

Sep 07, 2018: Teva returns laquinimod global rights to Active Biotech

Aug 09, 2018: Active Biotech-interim report January-June 2018

May 18, 2018: Annual General Meeting of Active Biotech

May 17, 2018: Active Biotech: Interim report January-March 2018

Feb 15, 2018: Active Biotech: Year-end report January-December 2017

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Active Biotech AB, Performance Chart (2014-2018)

Active Biotech AB, Ratio Charts

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Active Biotech AB, Key Facts

Active Biotech AB, Key Employees

Active Biotech AB, Key Employee Biographies

Active Biotech AB, Major Products and Services

Active Biotech AB, History

Active Biotech AB, Subsidiaries

Active Biotech AB, Key Competitors

Active Biotech AB, Ratios based on current share price

Active Biotech AB, Annual Ratios

Active Biotech AB, Annual Ratios (Cont...1)

Active Biotech AB, Interim Ratios

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Active Biotech AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Active Biotech AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Active Biotech AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts